The novel fused pyrimidine derivatives having tyrosine kinase activity inhibitory action

The present invention relates to a novel fused pyrimidine derivatives having tyrosine kinase inhibitory activity, pharmaceutical compositions containing the novel compounds of the present invention as an active ingredient, a cancer, tumor, inflammatory diseases, autoimmune diseases or immune-mediated diseases It provides an effect of treating or preventing.